Stresscopin (Human)

Documents

Thr-Lys-Phe-Thr-Leu-Ser-Leu-Asp-Val-Pro-Thr-Asn-Ile-Met-Asn-Leu-Leu-Phe-Asn-Ile-Ala-Lys-Ala-Lys-Asn-Leu-Arg-Ala-Gln-Ala-Ala-Ala-Asn-Ala-His-Leu-Met-Ala-Gln-Ile-NH₂
: (M.W. 4367.1) C₁₉₅H₃₂₆N₅₆O₅₃S₂
: Selective Ligand for Type 2 CRF Receptors

Package	Price(Yen)	Availability
Vial 0.1 mg	16,000	Ships within 1-3 business days
Bulk Request

Solubility: H₂O (0.1 mM)

S.Y. Hsu and A.J.W. Hsueh, Nat. Med., 7, 605 (2001). (Original)
F.M. Dautzenberg and R.L. Hauger, Trends Pharmacol. Sci., 23, 71 (2002). (Review)
V. Martínez, L. Wang, J.E. Rivier, W. Vale, and Y Taché, J. Pharmacol. Exp. Ther., 301, 611 (2002). (Pharmacol.)
A. Chanalaris, K.M. Lawrence, A. Stephanou, R.D. Knight, S.Y. Hsu, A.J.W. Hsueh, and D.S. Latchman, J. Mol. Cell. Cardiol., 35, 1295 (2003). (Pharmacol.)
C.L. Chang and S.Y.T. Hsu, Peptides, 25, 1681 (2004). (Review)
E.A. Woodcock, Endocrinology, 145, 21 (2004). (Review)
Y. Kuperman and A. Chen, Trends Endocrinol. Metab., 19, 122 (2008). (Review)
W.H. Pan and A.J. Kastin, Prog. Neurobiol., 84, 148 (2008). (Review)
P. Boonprasert, N. Lailerd, and N. Chattipakorn, Int. J. Cardiol., 127, 307 (2008). (Review)

Data Sheet